Goldman Sachs analyst Rajan Sharma upgraded Genmab A/S (GEN:DC) (NASDAQ: GMAB) from Neutral to Buy with a price target of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE